Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase involved in cell
proliferation, invasion, angiogenesis, and metastasis in various cancers, including …

Histone methylations play important roles in human cancer metastasis. Enhancer of zeste
homolog 2 (EZH2) is a key component of the polycomb repressor complex 2, which is …

Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, catalyzes tri-methylation
of histone H3 at Lys 27 (H3K27me3) to regulate gene expression through epigenetic …

Enhancer of zeste homolog 2 (EZH2) is suggested to be a potential therapeutic target and a
diagnostic marker for cancer. Our previous study also showed the critical role of EZH2 in …

Epigenetic alterations and microRNA (miRNA) deregulation are common in hepatocellular
carcinoma (HCC). The histone H3 lysine 27 (H3K27) tri‐methylating enzyme, enhancer of …

Enhancer of Zeste Homologue 2 (EZH2), a specific histone 3 lysine 27 (H3K27)
methyltransferase, plays a critical role in tumorigenesis and cancer progression through …

Enhancer of zeste homolog 2 (EZH2) is often increased in malignant tumors and is involved
in metastasis. EZH2 silences gene expression by tri-methylating the lysine 27 residue of …

The histone-lysine N-methyltransferase, enhancer of zeste homologue 2 (EZH2), functions
as a transcriptional repressor and plays an important role in the development of various …

EZH2, as a histone methyltransferase, has been associated with cancer development and
metastasis possibly through the regulation of microRNAs and cellular pathways such as …

Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase and a catalytic
component of PRC2, catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) to …